The Rise and Rise of Science Festivals: An international review of organised events to celebrate science
![Electrochemically Stable, High Transference Number Lithium Bis(malonato)borate Polymer Solution Electrolytes | Chemistry of Materials Electrochemically Stable, High Transference Number Lithium Bis(malonato)borate Polymer Solution Electrolytes | Chemistry of Materials](https://pubs.acs.org/cms/10.1021/acs.chemmater.9b05219/asset/images/large/cm9b05219_0008.jpeg)
Electrochemically Stable, High Transference Number Lithium Bis(malonato)borate Polymer Solution Electrolytes | Chemistry of Materials
![Polymers | Free Full-Text | Development of Covalent Triazine Frameworks as Heterogeneous Catalytic Supports Polymers | Free Full-Text | Development of Covalent Triazine Frameworks as Heterogeneous Catalytic Supports](https://pub.mdpi-res.com/polymers/polymers-11-01326/article_deploy/html/images/polymers-11-01326-g001.png?1566975596)
Polymers | Free Full-Text | Development of Covalent Triazine Frameworks as Heterogeneous Catalytic Supports
Discovery of the Dual Orexin Receptor Antagonist [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia | Journal of Medicinal Chemistry
![33419-42-0|(5R,5aR,8aR,9S)-9-(((4aR,6R,7R,8R,8aS)-7,8-Dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one|CsnPharm 33419-42-0|(5R,5aR,8aR,9S)-9-(((4aR,6R,7R,8R,8aS)-7,8-Dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one|CsnPharm](https://file.csnpharm.com/static/upload/proimg/200/214/33419-42-0.png)
33419-42-0|(5R,5aR,8aR,9S)-9-(((4aR,6R,7R,8R,8aS)-7,8-Dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one|CsnPharm
![Discovery and Development of Simeprevir (TMC435), a HCV NS3/4A Protease Inhibitor | Journal of Medicinal Chemistry Discovery and Development of Simeprevir (TMC435), a HCV NS3/4A Protease Inhibitor | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm401507s/asset/images/medium/jm-2013-01507s_0029.gif)
Discovery and Development of Simeprevir (TMC435), a HCV NS3/4A Protease Inhibitor | Journal of Medicinal Chemistry
![Clinical management of cerebral small vessel disease: a call for a holistic approach | Chinese Medical Journal Clinical management of cerebral small vessel disease: a call for a holistic approach | Chinese Medical Journal](https://mednexus.org/cms/asset/05add4ed-8f92-497b-a88b-ddd72db33345/cmj.2021.134.issue-02.cover.jpg)
Clinical management of cerebral small vessel disease: a call for a holistic approach | Chinese Medical Journal
![RNA interference in dermal and fibrotic indications Patent Grant Khvorova , et al. February 9, 2 [Phio Pharmaceuticals Corp.] RNA interference in dermal and fibrotic indications Patent Grant Khvorova , et al. February 9, 2 [Phio Pharmaceuticals Corp.]](https://uspto.report/patent/grant/10913948/US10913948-20210209-C00005.png)